博士（薬学）

大阪薬科大学

大阪大学医学部附属病院　　文部科学技官（薬剤師）
大阪大学大学院薬学研究科　講師
市立芦屋病院　　　　　　　薬剤部長

日本緩和医療学会：渉外委員会委員
日本緩和医療薬学会：理事　総務委員会委員長
日本ホスピス緩和ケア協会：理事
日本サイコオンコロジー学会：代議員　多職種協働委員会委員　ガイドライン策定委員会せん妄小委員会
日本がんサポーティブケア学会：代議員　教育委員会委員
日本医療薬学会：代議員
日本病院薬剤師会：代議員、認定小委員会委員
兵庫県病院薬剤師会：副会長
兵庫県薬剤師会：常務理事、編集文化部部長、学術倫理審査委員会委員長
日本ホスピス・緩和ケア研究振興財団　事業委員
ヨーロッパ緩和ケア学会（European Association for Palliative Care: EAPC）

15th World Congress of the European Association for Palliative Care　ポスター賞
2020年　日本サイコオンコロジー学会　教育功労賞
2022年　薬事功労賞（知事賞）
2022年　薬事協会長表彰

緩和医療

緩和医療、疼痛、薬物治療　補完代替医療

緩和薬物療法、予後予測

主な原著論文

1.Yoshinobu Matsuda, Hitoshi Tanimukai, Shinichiro Inoue, Takatoshi Hirayama, Yusuke Kanno, Yuichi Kitaura, Shuji Inada, Koji Sugano, Masafumi Yoshimura, Saki Harashima, Saho Wada, Takaaki Hasegawa, Yoshiaki Okamoto, Chikako Dotani, Mari Takeuchi, Jun Kako, Ryoichi Sadahiro, Yasuhiro Kishi, Megumi Uchida, Asao Ogawa, Masatoshi Inagaki, Toru Okuyama. A revision of JPOS/JASCC clinical guidelines for delirium in adult cancer patients: a summary of recommendation statements. Jpn J Clin Oncol. 2023 Aug 30;53(9):808-822. doi: 10.1093/jjco/hyad042.

2.Nakagawa S, Tsuji K, Ishida S, Tsunoda N, Okamoto Y. Comparison of the Effects of Diuretics on Pedal Edema in Patients with Cancer. Palliat Med Rep. 2022 Aug 18;3(1):162-168. doi: 10.1089/pmr.2022.0017. eCollection 2022 PMID: 36059912

3.Tanaka I, Okamoto Y, Takahashi Y, Asada S, Numata C. Are Corticosteroids Useful for End-stage Cancer Patients? A Retrospective Chart Review in the Palliative Care Unit. Jpn. J. Pharm Palliet Care Sci, VOL.14 No.2 June 2021

4.Niki K, Okamoto Y, Ueda M. Response to Wang et al., Virtual Reality as a Bridge in Palliative Care during COVID-19. J Palliat Med. 2020 Jul;23(7):892-894. doi: 10.1089/jpm.2020.0261. Epub 2020 May 11.

5.Hashimoto M, Aogaki K, Numata C, Moriwaki K, Matsuda Y, Ishii R, Tanaka I, Okamoto Y. Factors influencing the prescribed dose of opioid analgesics in cancer patients. J Opioid Manag. 2020 Jul/Aug;16(4):247-252. doi: 10.5055/jom.2020.0578.

6.Matsuda Y, Tanimukai H, Inoue S, Inada S, Sugano K, Hasuo H, Yoshimura M, Wada S, Dotani C, Adachi H, Okamoto Y, Takeuchi M, Fujisawa D, Kako J, Sasaki C, Kishi Y, Akizuki N, Inagaki M, Uchitomi Y, Matsushima E, Okuyama T. JPOS/JASCC clinical guidelines for delirium in adult cancer patients: a summary of recommendation statements. Jpn J Clin Oncol. 2020 May 5;50(5):586-593. doi: 10.1093/jjco/hyaa003.

7.Niki K, Okamoto Y, Maeda I, Ueda M. Responses to Kako et al. (DOI: 10.1089/jpm.2019.0072) and Niki et al. (DOI: 10.1089/jpm.2018.0233): A Novel Palliative Care Approach Using Virtual Reality for Improving Various Symptoms of Terminal Cancer Patients: A Preliminary Prospective, Multicenter Study. J Palliat Med. 2019 Dec;22(12):1490. doi: 10.1089/jpm.2019.0487. No abstract available.

8.Niki K, Okamoto Y, Matano Y, Ishii R, Matsuda Y, Takagi T, Uejima E. Validation of a Short-Term, Objective, Prognostic Predictive Method for Terminal Cancer Patients in a Palliative Care Unit Using a Combination of Six Laboratory Test Items. J Palliat Med. 2019 Jun;22(6):685-690. doi: 10.1089/jpm.2018.0422. Epub 2019 Jan 14.

9.Niki K, Okamoto Y, Maeda I, Mori I, Ishii R, Matsuda Y, Takagi T, Uejima E. A Novel Palliative Care Approach Using Virtual Reality for Improving Various Symptoms of Terminal Cancer Patients: A Preliminary Prospective, Multicenter Study. J Palliat Med. 2019 Jun;22(6):702-707. doi: 10.1089/jpm.2018.0527. Epub 2019 Jan 24.

10.Adachi T, Sunohara M, Enomoto K, Sasaki K, Sakaue G, Fujita Y, Mizuno Y, Okamoto Y, Miki K, Yukioka M, Nitta K, Iwashita N, Kitagawa H, Shibata M, Sasaki J, Jensen M, Fukui S. Japanese cross-cultural validation study of the Pain Stage of Change Questionnaire. PAIN Reports, Volume 4 - Issue 2 - p e711

11.Niki K, Okamoto Y, Maeda I, Mori I, Ishii R, Matsuda Y, Takagi T, Uejima E. A Novel Palliative Care Approach Using Virtual Reality for Improving Various Symptoms of Terminal Cancer Patients: A Preliminary Prospective, Multicenter Study. J Palliat Med. 2019 Jan 24. doi: 10.1089/jpm.2018.0527. [Epub ahead of print]

12.Niki K, Okamoto Y, Matano Y, Ishii R, Matsuda Y, Takagi T, Uejima E. Validation of a Short-Term, Objective, Prognostic Predictive Method for Terminal Cancer Patients in a Palliative Care Unit Using a Combination of Six Laboratory Test Items. J Palliat Med. 2019 Jan 14. doi: 10.1089/jpm.2018.0422. [Epub ahead of print]

13.Okamoto Y, Morita T, Tsuneto S, Aoyama M, Kizawa Y, Shima Y, Miyashita M*. Bereaved Family Members' Perceptions of the Distressing Symptoms of Terminal Patients with Cancer. Am J Hosp Palliat Care. 2018 Jul;35(7):972-977. doi: 10.1177/1049909118765409.

14.Niki K, Okamoto Y, Nakajima S, Uejima E*. The analgesic effect of rescue administration of intravenous acetaminophen in cancer patients may be associated with sex and opioid dose, and the effect would appear to patients administered under 45 mg/day opioid (oral morphine equivalents). Pharmazie 2018 73(3):161-164. doi: 10.1691/ph.2018.7878.

15.Miyashita M, Aoyama M, Yoshida S, Yamada Y, Abe M, Yanagihara K, Shirado A, Shutoh M, Okamoto Y, Hamano J, Miyamoto A, Nakahata M*. The distress and benefit to bereaved family members of participating in a post-bereavement survey. Jpn J Clin Oncol. 2018 Feb 1;48(2):135-143. doi: 10.1093/jjco/hyx177.

16.Niki K, Okamoto Y, Tabata Y, Tsugane M, Murata T, Mizuki M, Matsumura Y, Takagi T, Uejima E*. A New Approach for Determining Short-Term, Objective Prognostic Predictive Methods for Terminal Cancer Patients Based on the Change Point of Laboratory Test Values. J Palliat Med. 2017 Nov 17. 529-532. doi: 10.1089/jpm.2017.0233.

17.Okamoto Y, Tsuneto S, Morita T, Takagi T, Shimizu M, Miyashita M, Uejima E, Shima Y*. Desirable Information of Opioids for Families of Patients with Terminal Cancer: The Bereaved Family Members' Experiences and Recommendations. Am J Hosp Palliat Care. 2017 Apr;34(3):248-253. doi: 10.1177/1049909115626701.

18.Miyashita M, Aoyama M, Nakahata M, Yamada Y, Abe M, Yanagihara K, Shirado A, Shutoh M, Okamoto Y, Hamano J, Miyamoto A, Yoshida S, Sato K, Hirai K, Morita T*. Development the Care Evaluation Scale Version 2.0: a modified version of a measure for bereaved family members to evaluate the structure and process of palliative care for cancer patient. BMC Palliat Care. 2017 Jan 23;16(1):8.
19.Tanimukai H, Tsujimoto H, Matsuda Y, Watanabe M, Tsujio I, Maeda I, Takei K, Nakajima S, Taira T, Tokuyama M, Kai T, Okamoto Y, Goya S, and Kashiwagi Y. Novel Therapeutic Strategies for Delirium in Patients With Cancer:Preliminary Study. Am J Hosp Palliat Care. 2016 Jun;33(5):456-62. doi: 10.1177/1049909114565019.
20.Akashi N, Okamoto Y, Takei K, Nakagawa S, Tanaka I, Mita A, Shindo K，Can a novel diuretic Tolvaptan improve the edema of advanced cancer patients? . PALLIATIVE MEDICINE Vol.28 No.6, 888, 2014 Impact Factor:3.75
21.Okamoto Y, Tsuneto S, Tanimukai H, Matsuda Y, Ohno Y, Tsugane M, Uejima E. Can Gradual Dose Titration of Ketamine for Management of Neuropathic Pain Prevent Psychotomimetic Effects in Patients with Advanced Cancer? Am J Hosp Palliat Care. 2013 Aug;30(5):450-4. doi: 10.1177/1049909112454325.
22.Tanimukai H, Murai T, Okazaki N, Matsuda Y, Okamoto Y, Kabeshita Y, Ohno Y, Tsuneto S．An Observational Study of Insomnia and Nightmare Treated With Trazodone in Patients With Advanced Cancer. Am J Hosp Palliat Care. 2013 Jun;30(4):359-62. doi: 10.1177/1049909112452334.
23.Nagase M, Okamoto Y, Tsuneto S, Tanimukai H, Matsuda Y, Okishiro N, Ohno Y, Tsugane M, Takagi T, Uejima E．A Retrospective Chart Review of Terminal Patients with Cancer with Agitation and Their Risk Factors. J Palliat Med. 15(11): 2012
24.Tanimukai H, Murai T, Okazaki N, Matsuda Y, Okamoto Y, Kabeshita Y, Ohno Y, Tsuneto S. An Observational Study of Insomnia and Nightmare Treated With Trazodone in Patients With Advanced Cancer. Am J Hosp Palliat Care. 2013 Jun;30(4):359-62. doi: 10.1177/1049909112452334.
25.Nakagawa S, Okamoto Y, Tsuneto S, Tanimukai H, Goya S, Matsuda Y, Ohno Y, Tsugane M, Uejima E. Can milnacipran used for neuropathic pain in patients with advanced cancer cause neuromuscular and somatosensory disorders? J Palliat Med. 2011 Apr;14(4):403-5. doi: 10.1089/jpm.2010.0485.
26.Yoshiaki Okamoto , Satoru Tsuneto, Mamiko Tsugane, Tatsuya Takagi, Etsuko Uejima. A retrospective chart review of opioid-induced nausea and somnolence on commencement for cancer pain treatment. J Opioid Manag. 2010 Nov-Dec;6(6):431-4. doi: 10.5055/jom.2010.0041.
27.Yoshiaki Okamoto , Keiko Tazumi, Yasuaki Sanada, Mamiko Tsugane, Etsuko Uejima. Light-induced deterioration test of carboplatin under clinical settings. Yakugaku Zasshi. 2010 Oct;130(10):1369-74. doi: 10.1248/yakushi.130.1369.
28.Sari Nakagawa , Yoshie Toya, Yoshiaki Okamoto, Satoru Tsuneto, Sho Goya, Hitoshi Tanimukai, Yoichi Matsuda, Yumiko Ohno, Hiroshi Eto, Mamiko Tsugane, Tatsuya Takagi, Etsuko Uejima. Can anti-infective drugs improve the infection-related symptoms of patients with cancer during the terminal stages of their lives? J Palliat Med. 2010 May;13(5):535-40. doi: 10.1089/jpm.2009.0336.
29.Yoshiaki Okamoto , Satoru Tsuneto, Yoichi Matsuda, Takaya Inoue, Hitoshi Tanimukai, Keiko Tazumi, Yumiko Ono, Nobuo Kurokawa, Etsuko Uejima. A retrospective chart review of the antiemetic effectiveness of risperidone in refractory opioid-induced nausea and vomiting in advanced cancer patients. J Pain Symptom Manage. 2007 Aug;34(2):217-22. doi: 10.1016/j.jpainsymman.2006.10.020. Epub 2007 Jun 4.

最近の著書
１．荒尾　晴恵，岡本　禎晃　がん緩和ケア薬　必携ガイドブック　南江堂　2024年3月
２．谷向　仁，岡本　禎晃　その精神症状どうします？初めの処方・次の処方　南江堂　2023年5月
３．細谷　美紀，里見　絵理子，岡本　禎晃　がん疼痛治療薬まるわりBOOK第2版　照林社　2023年9月
４．岡本　禎晃　緩和医療薬学　改訂第2版　南江堂　2023年4月
５．岡本　禎晃（分担執筆）．がん支持医療テキストブック　サポーティブケアとサバイバーシップ　金原出版　2022年10月
６．岡本　禎晃（分担執筆）．臨床腫瘍薬学 第2版　じほう　2022年9月
７．岡本　禎晃（分担執筆）．終末期ケア上級専門士　公式テキスト
８．岡本　禎晃（分担執筆）．言語聴覚士のためのパーキンソン病のリハビリテーションガイド　協同医書出版社　2019年7月
９．岡本　禎晃，荒井　幸子編集．がん緩和ケアの薬の使い方　じほう　2019年6月
１０．恒藤　暁　岡本　禎晃．緩和ケアエッセンシャルドラッグ第4版　医学書院　2019年3月

兵庫県薬剤師会常務理事
兵庫県病院薬剤師会副会長

【看護学部】

臨床栄養学、臨床薬理学

【大学院】

臨床薬理学

【助産学専攻科】

周産期の基礎科学（薬理学・栄養学）

研究テーマも臨床の専門分野も緩和ケアです。